Related Experiment Video
Updated: Aug 21, 2026
Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
Medulloblastoma Forms Symbiotic Metabolic Partnerships with Macrophages to Establish Leptomeningeal Metastases
Abstract:
Leptomeningeal metastases are the primary source of morbidity and mortality for pediatric medulloblastoma patients. Due to limited surgical sampling of metastases in patients, little is understood of the mechanisms of metastasis. Here, we identify biologically distinct quiescent small metastases (designated as micrometastases) and mitotically active larger metastases (macrometastases). Macrometastases are more metabolically active than micrometastases and contain higher levels of lipids, particularly cholesterol. Macrometastases secrete CXCL12, which attracts lipid-laden macrophages into the tumor. Lipid-laden macrophages upregulate the cholesterol transporter ABCG1, promoting the efflux of free cholesterol, which is then taken up by tumor cells via the HDL receptor SCARB1. CXCL12-driven macrophage recruitment and exogenous cholesterol are sufficient and necessary to drive progression of medulloblastoma leptomeningeal metastases in vivo. High fat diets drive metastatic progression in vivo. Dietary or pharmacological interventions targeting the CXCL12-SCARB1-cholesterol axis represent therapeutic strategies to either prevent or treat medulloblastoma leptomeningeal metastases.
Insights
Pediatric medulloblastoma metastasis involves distinct tumor sizes. Cholesterol uptake via macrophages, driven by CXCL12, fuels larger tumor growth and spread, suggesting new therapeutic targets.
Area of Science:
- Oncology
- Cancer Metastasis
- Molecular Biology
Background:
- Leptomeningeal metastases are a major cause of death in pediatric medulloblastoma.
- Understanding medulloblastoma metastasis mechanisms is limited by sparse patient tumor samples.
- Distinct tumor subtypes, micrometastases and macrometastases, exist within leptomeningeal disease.
Purpose of the Study:
- To elucidate the biological mechanisms driving medulloblastoma leptomeningeal metastasis.
- To identify key molecular players and cellular interactions in metastatic progression.
- To explore potential therapeutic targets for medulloblastoma leptomeningeal metastases.
Main Methods:
- Comparative analysis of micrometastases and macrometastases.
- Investigation of metabolic activity and lipid content in distinct metastatic populations.
- Assessment of the role of CXCL12, macrophages, cholesterol transport (ABCG1, SCARB1), and diet in metastasis progression in vivo.
Main Results:
- Macrometastases are more metabolically active, with higher cholesterol content than micrometastases.
- CXCL12 secreted by macrometastases recruits lipid-laden macrophages.
- Macrophage-derived cholesterol, facilitated by ABCG1 and SCARB1, drives metastatic growth; high-fat diets exacerbate this process.
Conclusions:
- Medulloblastoma leptomeningeal metastasis progression is driven by a CXCL12-macrophage-cholesterol axis.
- Targeting this axis, including cholesterol metabolism and dietary fat intake, offers potential therapeutic strategies.
- This study reveals distinct metastatic phenotypes and identifies critical pathways for intervention.
Related Concept Videos
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:17The Tumor Microenvironment